SHELL ASSET MANAGEMENT CO - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$37,000
+23.3%
6,314
-11.4%
0.00%0.0%
Q2 2022$30,000
-54.5%
7,127
+2.2%
0.00%
-50.0%
Q1 2022$66,000
-56.6%
6,973
-12.8%
0.00%
-33.3%
Q4 2021$152,000
-41.5%
7,997
+2.5%
0.00%
-50.0%
Q3 2021$260,000
-17.7%
7,804
-4.1%
0.01%0.0%
Q2 2021$316,000
-54.3%
8,134
-43.3%
0.01%
-57.1%
Q1 2021$691,000
+38.2%
14,345
+49.3%
0.01%
+40.0%
Q4 2020$500,0009,6060.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders